NCT06750796 The Half Swaddling Application on Infant Sleep Routine, Maternal Sleep Quality, Depression
| NCT ID | NCT06750796 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Infant, Newborn |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2023-05-18 |
| Primary Completion | 2025-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2023-05-18 with a primary completion date of 2025-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this prospective controlled study, it was aimed to examine the effects of half swaddling in term infants on infant sleep routine, maternal sleep quality and postpartum depression.
Eligibility Criteria
Inclusion Criteria: * 18-45 years old, * Term birth (single birth over 37 weeks), * After an uncomplicated pregnancy process, the delivery was completed by normal vaginal or cesarean delivery method, * Not using cigarettes, alcohol and stimulants, * BMI\<30, * Not working on night shift, * Stable vital signs, * Those who have not received infertility treatment, * Do not have a chronic disease (such as hypertension, diabetes mellitus), * Not experiencing serious depression, anxiety and stress, * Not having any organic or non-organic disease that can cause cognitive impairment (such as Delirium, Dementia, Intellectual Retardation, etc.), * No serious maternal complications, * Mothers who volunteered to participate in the study will be included in the study. For baby; * Birth weight over 2500 g, * Stable vital signs, * APGAR score above 7, * No serious neonatal complications, * Midwives without congenital malformations will be included in the study. Exclusion Criteria: * under 18 years old, * Preterm birth (under 37 weeks and/or multiple births), * Incomplete delivery by normal vaginal or cesarean delivery method after a complicated pregnancy process, * Using cigarettes, alcohol and stimulants, * BMI\>30, * Working night shift, * No stable vital signs, * Having received infertility treatment, * Having a chronic disease (such as hypertension, diabetes mellitus), * Experiencing severe depression, anxiety and stress, * Having any organic or non-organic disease that can cause cognitive impairment (such as Delirium, Dementia, Intellectual Retardation, etc.), * Serious maternal complication, * Mothers who do not volunteer to participate in the study will not be included in the study. For baby; * Birth weight of 2500 g and below, * No stable vital signs, * APGAR score below 7, * Serious neonatal complication, * Babies with congenital malformations will not be included in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06750796 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Infant, Newborn. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06750796 currently recruiting?
Yes, NCT06750796 is actively recruiting participants. Contact the research team at haticesut@yahoo.com for enrollment information.
Where is the NCT06750796 trial being conducted?
This trial is being conducted at Edirne, Turkey (Türkiye).
Who is sponsoring the NCT06750796 clinical trial?
NCT06750796 is sponsored by Tanta University. The trial plans to enroll 128 participants.